Hofseth Biocare ASA (0Q6H) Stock Statistics & Valuation Metrics

Hofseth Biocare ASA has a market cap or net worth of kr715.28M. The enterprise value is kr906.99M.

Hofseth Biocare ASA has 395,081,020 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hofseth Biocare ASA’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -49.09%.

The current PE Ratio of Hofseth Biocare ASA is -5.66. Hofseth Biocare ASA’s PEG ratio is 1.82.

In the last 12 months, Hofseth Biocare ASA had revenue of 257.42M and earned -123.41M in profits. Earnings per share was -0.30.

In the last 12 months, operating cash flow was -37.58M and capital expenditures -4.29M, giving a free cash flow of -42.48M billion.

Hofseth Biocare ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Hofseth Biocare ASA upcoming earnings date is Aug 22, 2025, TBA (Confirmed).

Hofseth Biocare ASA as a current ratio of 0.67, with Debt / Equity ratio of 876.97%

In the past 12 months, Hofseth Biocare ASA has paid 0.00 in taxes.

Hofseth Biocare ASA EV to EBITDA ratio is -12.09, with an EV/FCF ratio of -60.77.

Hofseth Biocare ASA has kr71.95M in cash and marketable securities with kr236.19M in debt, giving a net cash position of kr164.24M billion.

Gross margin is 31.46%, with operating margin of -44.28%, and net profit margin of -47.94%.

The average price target for Hofseth Biocare ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―